Skip to main navigation Skip to search Skip to main content

Genomic epidemiology of global VIM-producing Enterobacteriaceae

  • Yasufumi Matsumura
  • , Gisele Peirano
  • , Rebekah Devinney
  • , Patricia A. Bradford
  • , Mary R. Motyl
  • , Mark D. Adams
  • , Liang Chen
  • , Barry Kreiswirth
  • , Johann D.D. Pitout
  • University of Calgary
  • Kyoto University
  • Calgary Laboratory Services
  • AstraZeneca
  • Merck
  • J. Craig Venter Institute
  • Jackson Laboratory
  • Rutgers - The State University of New Jersey, Newark
  • University of Pretoria

Research output: Contribution to journal › Article › peer-review

71 Scopus citations

Abstract

Background: International data on the molecular epidemiology of Enterobacteriaceae with VIM carbapenemases are limited. Methods: We performed short read (Illumina) WGS on a global collection of 89 VIM-producing clinical Enterobacteriaceae (2008-14). Results: VIM-producing (11 varieties within 21 different integrons) isolates were mostly obtained from Europe. Certain integrons with blaVIM were specific to a country in different species and clonal complexes (CCs) (In87, In624, In916 and In1323), while others had spread globally among various Enterobacteriaceae species (In110 and In1209). Klebsiella pneumoniae was the most common species (n = 45); CC147 from Greece was the most prevalent clone and contained In590-like integrons with four different blaVIMs. Enterobacter cloacae complex was the second most common species and mainly consisted of Enterobacter hormaechei (Enterobacter xiangfangensis, subsp. steigerwaltii and Hoffmann cluster III). CC200 (from Croatia and Turkey), CC114 (Croatia, Greece, Italy and the USA) and CC78 (from Greece, Italy and Spain) containing blaVIM-1 were themost common clones among the E. cloacae complex. Conclusions: This study highlights the importance of surveillance programmes using the latest molecular techniques in providing insight into the characteristics and global distribution of Enterobacteriaceae with blaVIMs.

Original languageEnglish
Pages (from-to)2249-2258
Number of pages10
JournalJournal of Antimicrobial Chemotherapy
Volume72
Issue number8
DOIs
StatePublished - 1 Aug 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Genomic epidemiology of global VIM-producing Enterobacteriaceae'. Together they form a unique fingerprint.

Cite this